Could these medications help with conditions like MCAS (Mast Cell Activation Syndrome), fatigue, and even neurodegenerative diseases
NOTE: At the Center for Nutrition, of course we hold to the above standards
Brand-name semaglutide (Ozempic, Wegovy) typically costs $900$1,500 monthly out-of-pocket for uninsured patients, while tirzepatide (Mounjaro) ranges $1,100$1,600 monthly
Critically, this benefit was not solely dependent on the amount of weight lost
Conclusions GLP-1RA medications have progressed beyond another tool for clinicians to manage type 2 diabetes, overweight, and obesity to therapies with robust cardiovascular outcomes
Even with discounts, the prices can be daunting without insurance coverage